Evidence map›Paper›PMID 41314227›Full record

ArticleThe Lancet. Microbe2026

Transmission of extended spectrum β-lactamase-producing Escherichia coli and antimicrobial resistance gene flow across One Health compartments in eastern Africa: a whole-genome sequence analysis from a prospective cohort study.

Patrick Musicha, Mathew A Beale, Derek Cocker, Fiona A Oruru, Allan Zuza, Chifundo Salifu, George Katende, Sylvia Nanono, Fred Isaasi, Kondwani Chidziwisano and 7 more

Abstract read
In one paragraph

Article in The Lancet. Microbe, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Patrick MusichaMalawi Liverpool Wellcome Research Programme, Kamuzu University of Health Sciences, Blantyre, Malawi; Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.
Mathew A BealeWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.
Derek CockerMalawi Liverpool Wellcome Research Programme, Kamuzu University of Health Sciences, Blantyre, Malawi; Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, UK.
Fiona A OruruInfectious Disease Institute, Makerere University, Kampala, Uganda.
Allan ZuzaMalawi Liverpool Wellcome Research Programme, Kamuzu University of Health Sciences, Blantyre, Malawi.
Chifundo SalifuMalawi Liverpool Wellcome Research Programme, Kamuzu University of Health Sciences, Blantyre, Malawi.
George KatendeInfectious Disease Institute, Makerere University, Kampala, Uganda.
Sylvia NanonoInfectious Disease Institute, Makerere University, Kampala, Uganda.
Fred IsaasiInfectious Disease Institute, Makerere University, Kampala, Uganda.
Kondwani ChidziwisanoMalawi University of Business and Applied Sciences, Blantyre, Malawi.
Lawrence MugishaCollege of Veterinary Medicine, Animal Resources and Biosecurity, Makerere University, Kampala, Uganda.
Henry KajumbulaCollege of Health Sciences, Makerere University, Kampala, Uganda.
David MusokeSchool of Public Health, Makerere University, Kampala, Uganda.
Tracy MorseDepartment of Civil and Environmental Engineering, University of Strathclyde, Glasgow, UK.
Shevin T JacobDepartment of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK; Walimu, Kampala, Uganda.
Nicholas A FeaseyMalawi Liverpool Wellcome Research Programme, Kamuzu University of Health Sciences, Blantyre, Malawi; Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK; School of Medicine, University of St Andrews, St Andrews, UK.
Nicholas R ThomsonWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK; London School of Hygiene & Tropical Medicine, London, UK. Electronic address: pm13@sanger.ac.uk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe One Health paradigm considers interdependence of human, animal, and environmental health. However, there is little evidence from high-income countries to support the importance of a One Health approach to addressing spread of antimicrobial resistance (AMR). Given AMR is a global threat, understanding how the close interactions of humans with animals and the environment in low-income settings affect the spread of AMR is important. We aimed to investigate diversity and transmission of extended spectrum β-lactamase (ESBL)-producing Escherichia coli across household-linked One Health compartments using genomic data.

methodsWe sequenced whole genomes of ESBL-producing E coli isolates from humans, animals, and the environment from a prospective, longitudinal cohort study conducted in Malawi (April 29, 2019, to Dec 3, 2020) and Uganda (July 16, 2020, to Aug 6, 2021). In the cohort study, 259 households were enrolled at baseline in Malawi and 92 in Uganda from a mix of urban, peri-urban, and rural areas. Households were followed up at months 1, 3, and 6 in Malawi and at months 1, 2, and 4 in Uganda. Samples collected at each visit included human and animal stool, environmental samples from hand-contact areas, food, and water, and broader environmental samples such as river water. Samples were cultured in buffered peptone water and then ESBL chromogenic agar to isolate ESBL-producing E coli. ESBL-producing E coli isolates underwent whole-genome sequencing. We performed phylogenetic analyses, and in-silico multi-locus sequence typing, characterised AMR determinants and linked genotypes with sample location, ecological source, and other covariates. We performed fine-scale single nucleotide polymorphism (SNP) and network analysis to infer strain and plasmid transmission across ecological compartments. The primary outcome was colonisation with ESBL-producing E coli. Secondary outcomes were genomic clusters and ESBL genomic determinants within and between One Health compartments.

findingsWe found high diversity of ESBL-producing E coli, with 170 sequence types and 166 genomic clusters identified from 2344 genomes, including 1814 genomes from Malawi (907 human, 221 animal, and 686 environmental) and 530 genomes from Uganda (380 human, 147 animal, and three environmental). Sequence type (ST)131 dominated in Malawi (209 [11·5%] of 1814 genomes), and ST10 dominated in Uganda (45 [8·5%] of 530 genomes). Common ESBL genes bla

interpretationOur work suggests that a One Health approach is crucial to addressing AMR in eastern Africa. Improving water, sanitation, and hygiene systems will create a safer environment, reduce spillovers of AMR bacteria between compartments, and eventually reduce AMR reservoirs in the environment and in animals.

fundingMedical Research Council, National Institute for Health and Care Research, and Wellcome Trust.

Indexed as

beta-LactamasesEscherichia coliEscherichia coli InfectionsAdultAnimalsAnti-Bacterial AgentsDrug Resistance, Multiple, BacterialFemaleGenome, BacterialHumansLongitudinal StudiesMalawiMaleOne HealthProspective StudiesUgandaAnti-Bacterial Agentsbeta-Lactamases

Identifiers

PMID41314227
PMCPMC12888559

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.